BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 1, 2017
View Archived Issues
ATYR-1940 granted U.S. orphan drug designation for the treatment of limb girdle muscular dystrophy
Read More
FDA grants orphan drug designation to ustekinumab for the treatment of pediatric ulcerative colitis
Read More
EMA committee hands down positive opinion for 8-week regimen of Viekirax + Exviera
Read More
FDA requests additional information to complete IND review for Titan's ropinirole implant
Read More
FDA awards fast track designation to Immunopulse IL-12 for metastatic melanoma
Read More
WHO publishes list of antibiotic-resistant priority pathogens
Read More
Sanofi seeks Japanese approval for dupilumab for atopic dermatitis
Read More
FDA grants rare pediatric disease designation to SB-318 for MPS I
Read More
Phase III pediatric study of Latuda for bipolar I depression meets primary endpoint
Read More
Immune Pharmaceuticals broadens enrollment criteria in bullous pemphigoid study of bertilimumab
Read More
Accera announces results from phase III study of AC-1204 for mild to moderate Alzheimer's disease
Read More
Bremelanotide improves desire and distress in hypoactive sexual desire disorder
Read More
miR-223 found to play a role in alcoholic liver disease
Read More
Astellas and Affinivax enter worldwide partnership for MAPS vaccine targeting pneumococcus
Read More
Vycellix and Moffitt Cancer Center establish collaborative research agreement
Read More
TGFB2 has a pathogenic role in Alzheimer's disease and dementia with Lewy bodies
Read More
Cancer Research UK and HitGen announce license agreement in lung cancer
Read More
Kevzara becomes available in Canada
Read More
Immunologic responses seen with vesigenurtucel-L in non-muscle invasive bladder cancer
Read More
FDA grants priority review to avelumab BLA for metastatic urothelial carcinoma
Read More
Johnson & Johnson completes acquisition of Abbott Medical Optics
Read More
Perrigo signs agreement to divest Tysabri royalty stream
Read More
FDA approves Xermelo for carcinoid syndrome diarrhea
Read More
ZUMA-1 study of axicabtagene ciloleucel meets primary endpoint of objective response rate
Read More
FDA accepts Dynavax's response to Heplisav-B complete response letter
Read More